Evidence map›Paper›PMID 27503318›Full record

ArticleEndocrine2016

HCG-mediated activation of mTORC1 signaling plays a crucial role in steroidogenesis in human granulosa lutein cells.

Molly B Moravek, Min Shang, Bindu Menon, Kmj Menon

Open access · greenAbstract read
In one paragraph

Article in Endocrine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Spatiotemporal Expression Inversion ofAnimals : an open access journal from MDPI · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. International journal of molecular sciences · 2022
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Role of mTOR Signaling in Female Reproduction.Frontiers in endocrinology · 2019
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Molly B Moravek *Department of Obstetrics and Gynecology, University of Michigan Hospitals and Health System, Ann Arbor, MI.
Min Shang *Department of Obstetrics and Gynecology, University of Michigan Hospitals and Health System, Ann Arbor, MI.
Bindu MenonDepartment of Obstetrics and Gynecology, University of Michigan Hospitals and Health System, Ann Arbor, MI.
Kmj MenonDepartment of Obstetrics and Gynecology, University of Michigan Hospitals and Health System, Ann Arbor, MI.
University of Michigan–Ann Arbor · US

Funding

Regulation Of Ovarian Function By GonadotropinR37HD006656 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MENON, JAIRAM K.M. · 2002 to 2011
$3.0M
REGULATION OF OVARIAN FUNCTION BY GONADOTROPINSR01HD006656 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MENON, JAIRAM K.M. · 1985 to 2017
$2.1M
NICHD NIH HHS R01 HD006656NICHD NIH HHS R37 HD006656
6 · The paper itself

Abstract

Luteinizing hormone/human chorionic gonadotropin stimulates progesterone biosynthesis in the corpus luteum by activating cyclic adenosine monophosphate/protein kinase A cascade. Recent studies have shown that cyclic adenosine monophosphate-mediated activation of protein kinase A interacts with the mammalian target of rapamycin signaling pathways. Furthermore, the use of mammalian target of rapamycin inhibitors for immunosuppression in transplant patients has shown adverse effects in reproductive functions. This study examined whether the mammalian target of rapamycin pathway plays any role in luteinizing hormone-mediated regulation of progesterone production. Human granulosa lutein cells were isolated from follicular aspirates of women undergoing in vitro fertilization. Cells were cultured for 72 h and treated with human chorionic gonadotropin (50 ng/ml) for different time periods with or without pretreatment with mammalian target of rapamycin complex 1 inhibitor, rapamycin, (20 nM) for 1 h. Expression of steroidogenic enzymes, including steroidogenic acute regulatory protein, cholesterol side chain cleavage enzyme, and 3β-hydroxysteroid dehydrogenase type 1 messenger RNA, were examined by real-time polymerase chain reaction after 6 h of human chorionic gonadotropin treatment. Expressions of phospho-ribosomal protein S6 kinase and cholesterol side chain cleavage enzyme were analyzed after 15 min and 24 h of human chorionic gonadotropin treatment, respectively. Progesterone production was analyzed by an enzyme immunoassay kit after human chorionic gonadotropin (50 ng/ml) or forskolin (10 μM) treatment for 24 h. Treatment with human chorionic gonadotropin increased the expression of downstream targets of mammalian target of rapamycin complex 1, as well as cholesterol side chain cleavage enzyme, 3β-hydroxysteroid dehydrogenase type 1 and steroidogenic acute regulatory protein messenger RNAs. These increases were inhibited by rapamycin pretreatment. Increased progesterone production in response to treatment with human chorionic gonadotropin or forskolin was also blocked by rapamycin pretreatment. Our findings support a role for mammalian target of rapamycin complex 1 in regulating steroidogenesis in human granulosa lutein cells.

Indexed as

3-Hydroxysteroid DehydrogenasesCells, CulturedCell SurvivalCholesterol Side-Chain Cleavage EnzymeChorionic GonadotropinFemaleHumansLuteal CellsMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesPhosphoproteinsPhosphorylationProgesteroneSignal TransductionSirolimusSteroidogenic Acute Regulatory Protein3-Hydroxysteroid DehydrogenasesCholesterol Side-Chain Cleavage EnzymeChorionic GonadotropinMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesPhosphoproteinsProgesteroneSirolimusSteroidogenic Acute Regulatory ProteinTOR Serine-Threonine KinasesHuman granulosa lutein cellsMammalian target of rapamycin complex 1 (mTORC1)Steroidogenesis

Identifiers

PMID27503318
PMCPMC5071160
OpenAlexW2475411806

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.